Decision Support in Missouri

bioMérieux is a global in vitro diagnostics leader headquartered in France, with significant US operations. The company manufactures and distributes comprehensive diagnostic solutions for clinical microbiology, molecular pathology, blood culture detection, immunoassays, and rapid point-of-care testing. Core competencies span microbial identification and antimicrobial susceptibility testing (ID/AST), sepsis diagnosis and management, infectious disease detection (respiratory pathogens, gastrointestinal pathogens), and blood culture systems. Key product platforms include BIOFIRE® FILMARRAY® multiplex PCR systems, VITEK® MS PRIME mass spectrometry, BACT/ALERT® VIRTUO® blood culture automation, and VIDAS® immunoassay analyzers. The company also serves pharmaceutical and food safety markets with quality control and environmental monitoring solutions. bioMérieux addresses critical clinical challenges including antimicrobial resistance (AMR) stewardship, rapid sepsis identification, and respiratory infection diagnostics. Offerings span hospital laboratories, point-of-care settings, and industrial applications. The company emphasizes diagnostic-driven clinical decision support, workflow automation, and integrated laboratory information management. Manufacturing includes automated detection systems, rapid molecular platforms, and MALDI-TOF mass spectrometry instruments. US operations distribute test kits, reagents, and instruments through multiple channels including direct sales and the bioMérieux eShop. The company holds multiple regulatory clearances including FDA 510(k) approvals and CE marking for diagnostic instruments and test kits.

Foresite Healthcare develops a passive, wearable-free monitoring platform designed for senior living communities and assisted living facilities. The solution provides continuous 24/7 gait analysis, vital sign trending, and sleep pattern monitoring to predict and prevent falls, detect acute illnesses (urinary tract infections, congestive heart failure, upper respiratory infections), and monitor cognitive decline. The platform uses advanced AI-driven predictive algorithms built on over 15 years of research and 20+ patented technologies. Core capabilities include fall risk prediction (up to three weeks in advance), instant fall detection with 97% accuracy and 7-second alert response, real-time vital sign analysis for early illness identification, sleep quality monitoring with restlessness tracking, and privacy-protected rewind analysis without facial recognition. The system is HIPAA-compliant and generates actionable insights through mobile-friendly dashboards to optimize staff efficiency and reduce manual monitoring burdens. Foresite serves senior communities, assisted living operators, and skilled nursing facilities, with documented results including reduced falls, decreased hospitalizations, improved length of stay, and enhanced caregiver workflows. The technology has been validated through clinical research and is deployed across multiple senior living organizations.